- $331.64m
- $817.56m
- $511.93m
- 84
- 78
- 85
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 229 | 291 | 351 | 453 | 512 |
Cost of Revenue | |||||
Gross Profit | 226 | 287 | 343 | 442 | 501 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 196 | 213 | 287 | 459 | 465 |
Operating Profit | 33 | 77.5 | 63.7 | -6.34 | 46.5 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 33 | 77.5 | 90.1 | 3.06 | 41.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33 | 77.5 | 89.8 | 3.34 | 39.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 33 | 77.5 | 25.6 | 7.1 | -1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 33 | 77.5 | 25.6 | 7.1 | -1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.3 | 0.705 | 1.45 | 0.112 | -0.067 |
Dividends per Share |